Prescription Drug Monitoring Programs: Ethical Issues in the Emergency Department

详细信息    查看全文

• 作者：Catherine A. Marco ; MD^a ; ^{cmarco2@aol.com" class="auth_mail" title="E-mail the corresponding author} ; Arvind Venkat ; MD^b ; Eileen F. Baker ; MD^c ; John E. Jesus ; MD^d ; Joel M. Geiderman ; MD^e ; For the ACEP Ethics Committee^&dagger ; ; Joel M. Geiderman ; MD ; FACEP ; Vidor Friedman ; MD ; FACEP ; Nathan G. Allen ; MD ; FACEP ; Andrew L. Aswegan ; MD ; FACEP ; Eileen F. Baker ; MD ; FACEP ; Kelly Bookman ; MD ; FACEP ; Jay M. Brenner ; MD ; FACEP ; Michelle Y. Delpier ; MD ; FACEP ; Arthur R. Derse ; MD ; JD ; FACEP ; Paul L. DeSandre ; DO ; FACEP ; Brian B. Donahue ; MD ; FACEP ; Hilary E. Fairbrother ; MD ; FACEP ; Kenneth V. Iserson ; MD ; MBA ; FACEP ; FIFEM ; John E. Jesus ; MD ; FACEP ; Nicholas H. Kluesner ; MD ; Heidi C. Knowles ; MD ; FACEP ; Chadd K. Kraus ; DO ; DrPH ; MPH ; Gregory L. Larkin ; MD ; MPH ; FACEP ; Walter E. Limehouse Jr. ; MD ; FACEP ; Catherine A. Marco ; MD ; FACEP ; Norine A. McGrath ; MD ; FACEP ; John Moskop ; PhD ; Shehni Nadeem ; EMRA Rep ; Elizabeth M. Phillips ; MD ; MA ; Mark S. Rosenberg ; DO ; MBA ; FACEP ; Raquel M. Schears ; MD ; FACEP ; Sachin J. Shah ; MD ; Jeremy Simon ; MD ; FACEP ; Robert C. Solomon ; MD ; FACEP ; Arvind Venkat ; MD ; FACEP ; David Wang ; MD ; Leslie Moore ; JD
• 刊名：Annals of Emergency Medicine
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：68
• 期：5
• 页码：589-598
• 全文大小：1211 K

文摘

Prescription drug monitoring programs are statewide databases available to clinicians to track prescriptions of controlled medications. These programs may provide valuable information to assess the history and use of controlled substances and contribute to clinical decisionmaking in the emergency department (ED). The widespread availability of the programs raises important ethical issues about beneficence, nonmaleficence, respect for persons, justice, confidentiality, veracity, and physician autonomy. In this article, we review the ethical issues surrounding prescription drug monitoring programs and how those issues might be addressed to ensure the proper application of this tool in the ED. Clinical decisionmaking in regard to the appropriate use of opioids and other controlled substances is complex and should take into account all relevant clinical factors, including age, sex, clinical condition, medical history, medication history and potential drug-drug interactions, history of addiction or diversion, and disease state.